Physician profile
Michael E Taylor
NPI 1437450343
$1,515.64
in general payments reported to CMS, 2019-2025
13 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $96.70 · 2022: $35.38 · 2023: $116 · 2024: $1,096 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $863 · Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $863.23 |
| Food and Beverage | $520.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $1,049.77 | 2024 | |
| Zimmer Biomet Holdings, INC. | $103.06 | 2023-2025 | Mymobility Platform |
| Cumberland Pharmaceuticals, INC. | $52.90 | 2023-2025 | Caldolor |
| Vertex Pharmaceuticals Incorporated | $45.44 | 2025 | |
| Bioventus LLC | $43.78 | 2023 | Supartz Fx Sodium Hyaluronate, L360 Thigh System |
| Pacira Pharmaceuticals Incorporated | $37.53 | 2021-2024 | Exparel |
| Amgen INC. | $37.52 | 2021-2025 | Evenity |
| Surgalign Spine Technologies, INC. | $32.25 | 2021 | |
| Highridge Medical LLC | $28.02 | 2024 | Biomet Ebi Bone Healing System |
| Ferring Pharmaceuticals INC. | $25.00 | 2025 | Euflexxa |
| Electronic Waveform Lab, INC. | $24.99 | 2021 | |
| Heron Therapeutics, INC. | $23.73 | 2022 | |
| Depuy Synthes Sales INC. | $11.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.